Successful transformation into a fully integarted CDMO
Over the last two years a significant and highly successful transformation has taken place at the Skyepharma site in Lyon, France.
The mission has been to transform the site into a fully integrated CDMO (Contract Development and Manufacturing Organisation) with services extending from early stage development and manufacturing through to packaging, serialisation and aggregation included .
The journey began in July 2016 and has been organised around four core strands of activity – culture change, pharmaceutical development growth, strong investments in industrial equipment and business development.
David Lescuyer’s testimony
David Lescuyer, President of Skyepharma tells about our journey to be a fully integrated CDMO in the interview by PharmaBoardRoom :